Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Chiral Technologies acquires oligos firm Arbor Biosciences
by Rick Mullin
January 25, 2019
| A version of this story appeared in
Volume 97, Issue 4
Seeking to expand its molecular biology services, Chiral Technologies, a division of Daicel specializing in enantioselective chromatography, will acquire Arbor Biosciences, a pharmaceutical services firm that generates oligonucleotide pools using massively parallel DNA synthesis technology. Arbor says it recently added a cell-free expression system using linear DNA as a template for rapid protein expression. Arbor, based in Ann Arbor, Michigan, will operate as a subsidiary of Daicel managed by Chiral Technologies.
Chemical & Engineering News
ISSN 0009-2347
Copyright © 2025 American Chemical Society
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X